Dozens of HIV experts at the Centers for Disease Control and Prevention received emails earlier in June revoking notices they ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.

A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Yeztugo was approved by the FDA ...

The launch of the injection faces potential threats, including the Trump administration’s proposed cuts to federal funding ...

Learning the best type of HIV prevention for those at highest risk can start with conversations about their options, writes ...

Although some HIV programs will remain, the proposed cuts in the fiscal year 2026 budget are too severe and will hinder HIV ...